The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services. Some federal ...
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given ...
Related: FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers The committee already has passed several bipartisan bills targeting "pay-for-delay" agreements, in which ...
The report also noted the FTC’s ongoing litigation against dealer marketing firm Traffic Jam Events, and refund payments sent to consumers in 2023 in the Napleton Auto case. Junk fees ...
It’s hard to find bipartisan consensus among lawmakers in Congress these days. But there’s widespread agreement on calls for pharmaceutical patent reform. The steep prices of brand-name drugs ...
Outrage from legions of Beyoncé and Taylor Swift fans about hidden concert ticket fees helped spark a national conversation around “junk fees." It has even filtered into the 2024 election cycle.
Google and YouTube were hit with a patent infringement lawsuit on May 28 in California Northern District Court. The court action, asserting a single patent related to streaming video to mobile ...
Kennedy Edgerton is an Updates Editor on the Mortgages and Loans team, leveraging his passion for writing and personal finance to produce stimulating content that empowers readers to enhance their ...
“[R]egulators may not care what the ostensible goal of a conspiracy is if they think it might harm competition. Indeed, the law generally does not recognize health and safety as justifications ...
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific ...